Company Filing History:
Years Active: 2000
Title: Michael J Merek: Innovator in Radiolabeled Protein Stabilization
Introduction
Michael J Merek is a notable inventor based in Albuquerque, Mexico. He has made significant contributions to the field of radiolabeled proteins and peptides, particularly in their stabilization against oxidation loss.
Latest Patents
Merek holds a patent titled "Post-labeling stabilization of radiolabeled proteins and peptides." This invention focuses on the use of ascorbic acid and its derivatives to stabilize radiolabeled proteins and peptides. The method involves adding ascorbic acid after the radiolabeling process, including any necessary incubation period, but before the administration to patients. This innovation addresses the critical issue of autoradiolysis and enhances the reliability of radiolabeled compounds in medical applications.
Career Highlights
Michael J Merek is associated with Rhomed Incorporated, where he applies his expertise in the development of innovative solutions in the biomedical field. His work has contributed to advancements in the stability and efficacy of radiolabeled substances, which are essential in various diagnostic and therapeutic procedures.
Collaborations
Merek collaborates with Paul O Zamora, leveraging their combined expertise to further enhance the impact of their innovations in the industry.
Conclusion
Michael J Merek's contributions to the stabilization of radiolabeled proteins and peptides represent a significant advancement in biomedical research. His innovative approach continues to influence the field positively.